NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Down 34.4% in March

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the target of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 134,000 shares, a decline of 34.4% from the February 28th total of 204,300 shares. Currently, 0.5% of the company’s shares are sold short. Based on an average daily trading volume, of 212,400 shares, the short-interest ratio is presently 0.6 days.

NeuroOne Medical Technologies Stock Down 4.7 %

NMTC stock traded down $0.04 during midday trading on Friday, reaching $0.86. The company’s stock had a trading volume of 35,858 shares, compared to its average volume of 146,994. The business’s 50-day simple moving average is $1.07 and its 200-day simple moving average is $0.94. NeuroOne Medical Technologies has a 52 week low of $0.55 and a 52 week high of $1.39. The stock has a market cap of $26.54 million, a PE ratio of -3.31 and a beta of 0.48.

NeuroOne Medical Technologies (NASDAQ:NMTC) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.06 EPS for the quarter. NeuroOne Medical Technologies had a negative return on equity of 270.70% and a negative net margin of 82.17%.

Institutional Trading of NeuroOne Medical Technologies

Large investors have recently bought and sold shares of the business. Jane Street Group LLC acquired a new stake in shares of NeuroOne Medical Technologies during the fourth quarter worth $33,000. Geode Capital Management LLC increased its holdings in NeuroOne Medical Technologies by 9.8% during the 4th quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock worth $257,000 after purchasing an additional 27,804 shares in the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of NeuroOne Medical Technologies in the 3rd quarter valued at about $26,000. 16.07% of the stock is owned by institutional investors.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.